Purchase Order N0017816P0124
Award Date 4/18/16
Potential Completion Date 5/18/16
Potential Value $112K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of one MiSeq System and a 12-month MiSeq Silver Support Plan, valued at $88,357.50. The contract was awarded on a sole-source basis under the authority of 10 U.S.C. 2304(c)(1), as the Naval Health Research Center requires Illumina's proprietary MiSeq technology for their...
- This is a firm fixed price purchase order contract awarded by the Naval Sea Systems Command (NAVSEA), a Defense agency, to Illumina, Inc. The contract has a ceiling value of $69,157.00 and a completion date of August 26, 2021. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing goods and services to support NAVSEA's nucleic acid sequencing needs, including reagents and controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing platforms used at...
- This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $249,894.20 contract is for the delivery of an Illumina MiSeq sequencing system, to be used at the agency's location in Rockville, Maryland. Illumina has provided similar sequencing systems and related supplies to support genomic research and diagnostics at various federal agencies, including...
- This is a $48,647 firm fixed price purchase order contract awarded by the U.S. Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer and provider of genomic sequencing and analysis solutions. The contract is for the purchase of Illumina's genetic sequencing products, including NextSeq, NovaSeq, MiSeq, and iSeq systems, as well as accompanying reagents, consumables, and support services. This award is part of a larger Indefinite Delivery Contract worth up to $3.3 million that...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
- This firm fixed-price purchase order contract was awarded by the Department of the Navy's Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $98,450.40, is to provide the agency with TruSeq Nano DNA Kits and MiSeq Reagent Kit V2 for genomic sequencing and analysis. This appears to be a delivery order under a larger Indefinite Delivery Contract worth up to $3.3 million that supports the Navy's nucleic acid...
- This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...
- This federal contract award was made by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $119,742.91 firm fixed price purchase order is for a MiSeq System, related reagents, and support services to be performed in San Diego, CA. The contract does not have a set-aside designation. The award was made on a sole source basis to Illumina, as the provider of the proprietary...
- This is a firm fixed price purchase order contract awarded by the U.S. Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The $102,361.40 contract is for the provision of NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This contract is not set aside for any...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract has a ceiling value of $217,662.22 and is for the provision of a MiSeq benchtop sequencer, associated reagent kits, and preventative maintenance services. The contract does not utilize any set-aside designations. Illumina has a history of providing sequencing systems, reagents, and support services to...